EUVIMEDEUVIMED entdecken
Crossref

Further confirmation of a highly prognostic grading scheme based upon tumour budding and cell cluster size in cervical squamous cell carcinoma

Wenwen Zhang, Yiling Song, Haiyan Shi, Bingjian Lu iD

Histopathology · 2025-05 · 86 (6) · 967-978

DOI: 10.1111/his.15404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, online erschienen am 27.12.2024. Verfasst von Wenwen Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Pathology, Womens Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Carcinoma, Squamous Cell, Neoplasm Grading. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Our study aimed to further confirm the clinical significance of the tumour budding activity and cell nest size‐based (TBNS) grading scheme in cervical squamous cell carcinomas (SCC). Methods and results We applied the TBNS system to assess the prognostic value in an institutional cohort of well‐annotated cervical SCC consisting of 312 consecutive cases with surgical resection, no neoadjuvant chemotherapy and higher than stage pT1a. We found that high budding activity, single cell and TBNS grade 3 were more frequently associated with a decreased overall survival (OS) time and disease‐free survival (DFS) time ( P < 0.001) and several other clinicopathological factors, including lymphovascular space invasion, lymph node metastasis, advanced Federation of Gynecology and Obstetrics (FIGO) stage and deep invasion of the cervical wall (> 2/3) ( P < 0.05). On multivariate analysis, TBNS grade 3 was an adverse indicator for OS and DFS independently of age, invasion of the cervical wall and FIGO stage ( P < 0.05). By comparison, the conventional three‐tiered grading system was not associated with OS and DFS in cervical SCC ( P > 0.05).

Conclusions

Our study further confirms that the TBNS grading scheme is robust in prognostic assessment in cervical SCC that outperforms the conventional three‐tiered grading system. It is applicable to add TBNS grade into routine diagnostic practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsCarcinoma, Squamous CellNeoplasm GradingHumansFemaleMiddle AgedPrognosisAdultAgedDisease-Free Survival

Stichwörter der Autor:innen

cell nest sizecervixgradingprognosissquamous cell carcinomatumour budding

Autor:innen und Institutionen

  • Department of Surgical Pathology, Womens Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China.
  • Department of Surgical Pathology, Huzhou Maternity and Child Health Care Hospital, Huzhou, China.
  • Department of Surgical Pathology and Center for Uterine Cancer Diagnosis and Therapy Research of Zhejiang Province, Womens Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China.
  • Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Hangzhou, Zhejiang Province, China.

ORCID-Profile: Bingjian Lu

Zitieren

APA

Zhang, W., Song, Y., Shi, H., & Lu, B. (2025). Further confirmation of a highly prognostic grading scheme based upon tumour budding and cell cluster size in cervical squamous cell carcinoma. Histopathology, 86(6), 967-978. https://doi.org/10.1111/his.15404

Vancouver

Zhang W, Song Y, Shi H, Lu B. Further confirmation of a highly prognostic grading scheme based upon tumour budding and cell cluster size in cervical squamous cell carcinoma. Histopathology. 2025;86(6):967-978. doi:10.1111/his.15404

BibTeX
@article{Zhang2025,
  author = {Zhang, Wenwen and Song, Yiling and Shi, Haiyan and Lu, Bingjian},
  title = {Further confirmation of a highly prognostic grading scheme based upon tumour budding and cell cluster size in cervical squamous cell carcinoma},
  journal = {Histopathology},
  year = {2025},
  volume = {86},
  number = {6},
  pages = {967--978},
  doi = {10.1111/his.15404}
}
Kostenlos starten →